Skip to search formSkip to main contentSkip to account menu

volociximab

Known as: anti-![GREEK SMALL LETTER ALPHA]!5![GREEK SMALL LETTER BETA]!1 integrin MOAB, anti-alpha 5 beta 1 integrin monoclonal antibody, anti-?5?1 integrin 
A monoclonal antibody that is being studied in the treatment of some types of cancer. Monoclonal antibodies are made in the laboratory and can locate… 
National Institutes of Health

Related topics

Related topics

5 relations

Narrower (1)

M200

Broader (1)

Monoclonal Antibodies
NCIt Antineoplastic Agent Terminologyantigen bindingdacarbazine/volociximab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Comparison of FDG whole-body PET / CT and gadolinium-enhanced whole-body MRI for distant malignancies in patients with malignant tumors : a meta-analysis
that specifically binds α5β1 integrin: a phase I, pharmacokinetic, and biological correlative study. Clin Cancer Res 2008; 14… 
2009
2009
State-ofthe-art treatment of metastatic renal cell carcinoma
s+%26+Virtual+Meeting/Abstracts?&vmview=abst_ detail_view&confID=47&abstractID=33225; cited January 19, 2009] 47. Rixe O… 
2009
2009
Gateways to clinical trials.
(-)-Gossypol; Abacavir sulfate/lamivudine, ACAM-1000, ACE-011, Agomelatine, AGS-004, Alemtuzumab, Alvocidib hydrochloride, AMG… 
2009
2009
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2006
2006
Phase II study of volociximab (M200), an {alpha}5{beta}1 anti-integrin antibody in metastatic melanoma
2005
2005
M200 (volociximab), a chimeric antibody against integrin alpha5 beta1, inhibits tumor growth by multiple mechanisms
Proc Amer Assoc Cancer Res, Volume 46, 2005 4497 Interactions between cells and extracellular matrix (ECM) proteins in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)